"
Team:Lyon-INSA/Achievements
From 2012.igem.org
(Difference between revisions)
| Line 51: | Line 51: | ||
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We have submitted | + | <div>We have submitted six <a href="https://2012.igem.org/Team:Lyon-INSA/datapage"><b>documented parts</b></a> to the registry and showed that they work as expected. Among them, two <b>improvements</b> for existing <i>B. subtilis</i> shuttle vectors : fully characterized plasmids, with the full BioBrick prefix and suffix for the first time in the registry.<br></div> |
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We explored <b>safety implications</b> of the project as a whole.<br></div> | + | <div>We have explored <a hrf="https://2012.igem.org/Team:Lyon-INSA/safety"><b>safety implications</b></a> of the project as a whole.<br></div> |
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We <b>collaborated</b> with | + | <div>We have <b>collaborated</b> with <a href="https://2012.igem.org/Team:British_Columbia">British Columbia (UBC) team</a> to exchange knowledge about Intellectual Property. Moreover, we exchange with the other french teams through the <a href="https://sites.google.com/site/igemfrance/">iGEM France website</a>.<br></div> |
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We have incorporated <b>Human Practices</b> and <b>Modelling</b> into our design.<br></div> | + | <div>We have incorporated <a href="https://2012.igem.org/Team:Lyon-INSA/humanPractice"><b>Human Practices</b></a> and <a href="https://2012.igem.org/Team:Lyon-INSA/modelling"><b>Modelling</b></a> into our design.<br></div> |
<br> <br> | <br> <br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We get our project closer to application by meeting with experts to consider <b>industrialization</b>.<br></div> | + | <div>We get our project closer to application by meeting with experts to consider <a href="https://2012.igem.org/Team:Lyon-INSA/Context"><b>industrialization</b></a>.<br></div> |
<br><br> | <br><br> | ||
<img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | <img src="https://static.igem.org/mediawiki/2012/9/9c/D%283%29.gif" width="3%"style="margin-right: 25px;"/> | ||
| - | <div>We presented our project and Synthetic Biology in many ways : on different <b>websites</b>, in <b>newspapers</b>, in <b>scientific events</b>, in order to inform a public as varied as possible.<br></div> | + | <div>We have presented our project and Synthetic Biology in many ways : on different <b>websites</b>, in <b>newspapers</b>, in <b>scientific events</b>, in order to inform a public as varied as possible.<br></div> |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 03:27, 27 September 2012
Achievements : What did we do ?
We have registered our team.
We have completed the judging form.
We have set up a team wiki.
We have prepared a poster and a presentation for the Jamboree.
We have submitted six documented parts to the registry and showed that they work as expected. Among them, two improvements for existing B. subtilis shuttle vectors : fully characterized plasmids, with the full BioBrick prefix and suffix for the first time in the registry.
We have explored safety implications of the project as a whole.
We have collaborated with British Columbia (UBC) team to exchange knowledge about Intellectual Property. Moreover, we exchange with the other french teams through the iGEM France website.
We get our project closer to application by meeting with experts to consider industrialization.
We have presented our project and Synthetic Biology in many ways : on different websites, in newspapers, in scientific events, in order to inform a public as varied as possible.
